脑酶水解物制药工艺的改进
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
脑酶水解物类药物是国内外广泛用于治疗脑血管类疾病的具有生物活性的特效药。本研究针对国内制药企业有关此类药物生产工艺相对滞后,影响药品质量的现况,通过检索大量文献,较为全面地了解了脑酶水解物类药物(主要有效成分为生物活性肽和氨基酸)的临床治疗效果和生产工艺的研究现状以及发展趋势,并对药厂脑酶水解物现行生产工艺进行了尝试性改进。通过大量的筛选优化实验的研究,确定了各生产环节的工艺参数,得出一整套具有安全性高、成本低、更为理想的脑酶水解物生产制药工艺。而且,该工艺生产出的脑酶水解物产品100%达到国家药品检验标准。为了更显著地提高临床治疗效果,本研究通过高效液相色谱(HPLC)对脑酶水解物做了进一步检测分析,初步确定了脑酶水解物生产工艺中水解选用最佳蛋白酶为胰蛋白酶。
Effective compositions in Cerebroprotein hydrolysate are Biologically active peptides and amino acids. The correlative medicine of Cerebroprotein hydrolysate has good biologically activity. It has outstanding effective treatement on correlative disease in blood vessel of brain and has been widely used in the world. After exploring the production technology of Cerebroprotein hydrolysate in some local pharmaceutical plants, we found that the production technology drops behind relatively and the quality of medicine is affected seriously. Through searching a large amount of documents, the research grasped the clinical result of treatment and the current situation of research in production technology of Cerebroprotein hydrolysate as well as it's development trend. Through a large amount of experiments, the research has carried some improvements on the original production technology of Cerebroprotein hydrolysate and has defined each technology parameter. As a result, the research has got the whole set of advanced
    technology in Cerebroprotein hydrolysate production which is highly safety, low cost and more ideal. The medicines produced by this technology have all reached the national pharmacy standard. For raising the clinical result of treatment further, we made HPLC analysis, the result have determined that the best type of enzyme is tyrpsin in production of Cerebroprotein Hydrolysate.
引文
1.张文志,苏心,秦进喜等.乳猪脑活性多肽的制备,成分分析及实验动物抗脑老化研究.天津医药,2001,29(5):293-296
    2.只达石,焦春凤,张竞宇等.强脑因子抗脑衰老作用的实验研究.天津医药,1995,23(3):137-140
    3.武剑,吴跃.脑活素治疗橄榄体脑桥小脑萎缩[J].新药与临床,1994,13(6):369
    4.金俊英.用脑活素治疗脑血管病.山西医学院学报,1990,21(3):188
    5.李云宝.脑活素治疗脑功能障碍的疗效观察.武汉医学杂志,1991,15(4):229
    6.王广玉.脑活素治疗新生儿缺氧血性脑病[J].新药与临床,1995,14(2):122
    7.张石革,袁伟晋,汤光.生化药物的进展与临床应用和市场前瞻.药业专论
    8.生物药物国内外现状及展望.中国药学会生化药物专业委员会.中国药学杂志,1997,32(11):694-697
    9.吴梧桐.生物制药工艺学.北京:中国医药科技出版社,1993,269
    10.侯淦泉等.胎牛脑活素注射液的研究.中国生化药物杂志,1996,17(2):53-55
    11.邹雁清,孔祥平,张宜俊等.乳猪脑提取物和脑活素对培养中肽鼠大脑皮质神经元的影响[J].天津医药,1994,22(11):661
    12.张杰,汪家政.神经营养素家族的临床应用前景.军事医学科学院院刊,1998,22(1):65-68
    13.罗斌等.新生牛脑低分子提取物对神经突起生长的作用.中国生物制品学杂志,1999,12(2):87-90
    14.周连冲.多肽生长因子[M].北京:中国科学技术出版社,1992,1-42.
    15.吴永佩等.中国新药杂志.1995,4(2):35
    16.梁铟,王晓葵.脑活素作用浅析.西安医科大学第一附属医院药剂科.
    17.王春艳,王广秀.脑活素对体外培养脑胶质瘤细胞的作用.天津市神经病学研究所.
    18.林元藻等.猪脑水解液的制备及其生物学活性研究[J].氨基酸和生物资源,1999,21(3):5-8
    19.河北医学院药厂,北京三达生化制药厂.脑组织注射液[s].冀卫药准字(1995)9416号.
    20.哈尔滨松鹤制药厂.脑蛋白水解物注射液[s].(95)卫药试字x—22—2号,
    21.朱炯,孙磊.脑蛋白水解物注射液质量考核结果.中国药事,1997,11(4):258-261
    22.刘海静等.脑活素简易检测法及国产脑活素研制品的质量考察.中国生化药物杂志,1997,18(3):147-149
    23.李筠.脑活素治疗新生儿缺氧性脑病33例疗效观察.临床儿科杂志,1996,14(1):8
    24.史荫绵等.脑活素治疗急性脑出血的临床研究.中国神经精神疾病杂志,1990,16(4):228
    
    
    25.马英杰.脑活素用于急性脑梗塞的临床观察.中国神经精神疾病杂志,1990,16(4):228
    26.王茶香.脑活素治疗脑血栓形成的疗效比较分析.浙江省淳交县第一人民医院内科.
    27.曲晓骅,丁梅.脑活素改善慢性呼吸衰竭精神神经症状的临床观察.北京市积水潭医院.
    28.庄宇德等.脑活素治疗流行性乙型脑炎26例疗效观察.
    29.孙桂莲,韩玉昆,毛健.丽珠塞乐治疗新生儿缺氧缺血性脑病观察.中国实用儿科杂志,1997,12(2):92
    30.愈永熹,黄观凤,李瑞娇.脑活素治疗中毒性脑病初步体会.福建生职业病防治院.
    31.王增禄,杨泽田,徐平西.脑活素对冷暴露大鼠脑能量转换的影响.中国医院药学杂志,1994,14(8):350
    32.王铭昌,高家山,杨传芝等.脑活素治疗脑血栓60例疗效观察.临床荟萃,1994,10(9):464
    33.王先川,房殿民,罗翠华等.脑活素治疗急性脑梗塞36例疗效观察.1994,14(9):661-662
    34.赵慧兰,樊真,肖映文.脑血管病治疗药物介绍.中国药学杂志,1991,26(6):367
    35.高玉民,李治淮,朱美财等.脑蛋白水解物动物长期毒性试验.空军总医院学报,2001,17(2):96-97
    36.钟玉旭,李复兰,邹立家等.动物脑酶水解物研究概况.中国生化药物杂志,1996,Vol.17(4):177-180
    37.Gschanes A,Valouskova V,Windisch M.Ameliorative influence of a nootropic drug on motor activity of rats after bilateral carotid artery occlusion.J Neural Transm,1997,104(11-12):1319-1327
    38.Windisch M,Piswanger A.Modification of rat brain metabolism by long-term treatment with a peptide derivative.Arzneimittelforschung,1985,35(9):1353-1356
    39.Gonzalez ME,Francis L,Gastellano O.Antioxidant systemic effect of shor-term Cerebrolysin administration.J Neural Transm Suppl,1998,53:333-341
    40.Schwab M,Antonow.Schlorke I,Zwiener U,et al.Brain-derived peptides reduce the size of cerebral infraction and loss of MAP2 immunoreactively after focal ischemia in rats.J Neural Trans m Suppl,1998,53:299-311
    41.Gschanes A,Windisch M.The infouence Of Cerebrolysin and E021 on spatial navigation of 24-month-old rats.J Neural Trans m Suppl,1998,53:313-321
    42.高玉民.脑蛋白水解物的一般药理研究.解放军药学学报,2000,16(1)
    43.欧阳鸿,牛勇,张欧等.脑活素对大鼠及小鼠缺氧的保护作用[J].解放军药学学报,1999,15(1):37
    
    
    44.窦肇华,蒙一纯,鲁志博等.胎脑注射液对老龄小鼠细胞免疫功能影响的研究[J].老年学杂志,1990,10(6):173-175
    45.苏州市脑安泰临床试用协作组.苏州医药,1980,6(4):12
    46.鲍祥凤.脑活素临床应用.中国医院药学杂志,1996,16(3):126-127
    47.满家就.脑活素在脑血管疾病中的应用.中国医院药学杂志,1996,16(6):274-275
    48.王忠秋.我医院注射液用生化药品用药分析.中国生化药物杂志,1999,20(5):258-259
    49.许昌泰.脑活素研究现状[J].临床荟萃,1996,11(15):696
    50. IlagLL, CutisR, Glass D,et al. Panneurotrophinl:agenetically engineered neurotrophie factor displaying multiple speeificties in perip-eral neurons in vitro.Proc Natl Acad Sci USA,1995, 92:607-611
    51. Radziejewski C,Robinson RC. Heterodimers of the neurotrophic factors: formation, isolation and differential stability, Biochemistry, 1993, 32:13350-13353
    52.孔德新.脑活口服液的制备及营养成分分析.食品科学,1996,17(10):54-55
    53.刘伟明,朱志国,冷红霞等.脑活素类生物制剂中铬、锰、钴、镍的测定[J].哈尔滨医科大学学报,2000,34(1):14-15
    54.刘伟明,窦肇华,董顺福等.脑细胞激活素中氨基酸、维生素和化学元素含量分析.东北师大学报自然科学报,2001,33(1):56-59
    55.刘伟明,冷红霞,刘巨涛等.各种脑活素中微量元素含量的比较.第四军医大学学报,2001,22(7):587-590
    56.纪宏,周淑平,高春.高效毛细管电泳法对脑活素注射液中多肽组分的分析.中国生化药物杂志,1999,20(3):145-147
    57.张佳程,罗承庠,张丽娟.水杨酸钠—次氯酸钠比色法测定食品中总凯氏氮的研究.中国农业大学,1999,32(1):18-21
    58.蔡英姬.猪胎脑活素注射液的研制.中国生化药物杂志,2000,21(1):12-14
    59.余礼碧,施燕,王占利.脑蛋白粉的制备及其酶解方法的研究.氨基酸和生物资源,2000,22(3):18-21